PT  - JOURNAL ARTICLE
AU  - Timothy, Jithender J.
AU  - Holla, Vijaya
AU  - Meschke, Günther
TI  - Multiscale dynamics of COVID-19 and model-based recommendations for 105 countries
AID  - 10.1101/2020.06.05.20123547
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.06.05.20123547
4099  - http://medrxiv.org/content/early/2020/06/07/2020.06.05.20123547.short
4100  - http://medrxiv.org/content/early/2020/06/07/2020.06.05.20123547.full
AB  - We analyse the dynamics of COVID-19 using computational modelling at multiple scales. For large scale analysis, we propose a 2-scale lattice extension of the classical SIR-type compartmental model with spatial interactions called the Lattice-SIRQL model. Computational simulations show that global quantifiers are not completely representative of the actual dynamics of the disease especially when mitigation measures such as quarantine and lockdown are applied. Furthermore, using real data of confirmed COVID-19 cases, we calibrate the Lattice-SIRQL model for 105 countries. The calibrated model is used to make country specific recommendations for lockdown relaxation and lockdown continuation. Finally, using an agent-based model we analyse the influence of cluster level relaxation rate and lockdown duration on disease spreading.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB approval was required as our paper is based on mathematical and computational analysis and no clinical tests are done.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesComputer code used in the paper is available on request.